p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation

Cell Cycle

Volumn 5, Issue 7, 2006, Pages 759-765

  Eymin, Beatrice ^a,b   Claverie, Paule ^a   Salon, Caroline ^a   Brambilla, Christian ^a   Brambilla, Elisabeth ^a   Gazzeri, Sylvie ^a  

^a INSERM   (France)

^b INSTITUT ALBERT BONNIOT   (France)

Author keywords

ARF; Cdc25C; G2 arrest; MAPK ERK1 2; Phosphorylation; Proteasome

Indexed keywords

CHECKPOINT KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEIN P14ARF; PROTEIN TYROSINE PHOSPHATASE; SERINE; CDC25C PROTEIN; CELL CYCLE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PHOSPHOSERINE; UBIQUITIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; CELL CULTURE; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G2 PHASE; GENE EXPRESSION; HUMANS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PHOSPHOSERINE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; UBIQUITIN;

EID: 33645716061     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.7.2625     Document Type: Article

References (42)

1. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9:180-6.
2. Fuchs SY, Adler V, Pincus MR, Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 1998; 95:10541-6.
3. Huang C, Ma WY, Maxiner A, Sun Y, Dong Z. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 1999; 274:12229-35.
4. Keller D, Zeng X, Li X, Kapoor M, Iordanov MS, Taya Y, Lozano G, Magun B, Lu H. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem Biophys Res Commun 1999; 261:464-71.
5. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001; 411:102-7.
6. 2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem 1999; 274:2732-42.
7. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002; 277:12710-7.
8. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003; 22:5885-96.
9. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 2000; 14:2358-65.
10. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 2002; 62:1171-7.
11. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Starck L, Guner D, Dorken B, Daniel PT. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax- independent apoptosis. Oncogene 2002; 21:3149-61.
12. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003; 11:415-24.
13. Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15-25.
14. 2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003; 22:1822-35.
15. Takizawa CG, Morgan DO. Control of mitosis by changes in the subcellular location of cyclin-B1- Cdk1 and Cdc25C. Curr Opin Cell Biol 2000; 12:658-65.
16. Bulavin DV, Higashimoto Y, Demidenko ZN, Meek S, Graves P, Phillips C, Zhao H, Moody SA, Appella E, Piwnica-Worms H, Fornace Jr AJ. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol 2003; 5:545-51.
17. Bulavin DV, Demidenko ZN, Phillips C, Moody SA, Fornace Jr AJ. Phosphorylation of Xenopus Cdc25C at Ser285 interferes with ability to activate a DNA damage replication checkpoint in premidblastula embryos. Cell Cycle 2003; 2:263-6.
18. Hutchins JR, Clarke PR. Many fingers on the mitotic trigger: Post-translational regulation of the Cdc25C phosphatase. Cell Cycle 2004; 3:41-5.
19. 2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277:1501-5.
20. Furnari B, Rhind N, Russell P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 1997; 277:1495-7.
21. Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, Gazzeri S. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 10:1033-1041.
22. 2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 2004; 279:25813-22.
23. Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 2004; 431:712-7.
24. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24:985-96.
25. Sherr CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998; 12:2984-91.
26. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602.
27. Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 1998; 395:125-6.
28. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol 2005; 25:220-32.
29. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998; 95:1091-6.
30. 2/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 1999; 96:11335-40.
31. 2/M transition induced by nocodazole. J Biol Chem 2000; 275:31876-82.
32. Roberts EC, Shapiro PS, Nahreini TS, Pages G, Pouyssegur J, Ahn NG. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol 2002; 22:7226-41.
33. Harding A, Giles N, Burgess A, Hancock JF, Gabrielli BG. Mechanism of mitosis-specific activation of MEK1. J Biol Chem 2003; 278:16747-54.
34. 2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene 2005.
35. Donzelli M, Draetta GF. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 2003; 4:671-7.
36. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277:1497-501.
37. 2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005; 17:37-48.
38. 2/M phase in immortalized skin keratinocytes with defective p53. Biochem Biophys Res Commun 2000; 277:107-11.
39. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 2000; 20:4543-52.
40. Raj K, Ogston P, Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001; 412:914-7.
41. 2 checkpoints. Proc Natl Acad Sci USA 2002; 99:14795-800.
42. Busino L, Chiesa M, Draetta GF, Donzelli M. Cdc25A phosphatase: Combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 2004; 23:2050-6.